210 results on '"Furling D"'
Search Results
2. FP.44 Exploring the role of MuscleBlind-Like proteins in the regulation of CaVB1 isoform expression in adult skeletal muscle
3. miR-7 Restores Phenotypes in Myotonic Dystrophy Muscle Cells by Repressing Hyperactivated Autophagy
4. Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions
5. MYASTHENIA & RELATED DISORDERS
6. Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1
7. The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy
8. Dysregulation of circular RNAs in myotonic dystrophy type 1
9. IGF-1 induces human myotube hypertrophy by increasing cell recruitment
10. Defective satellite cells in congenital myotonic dystrophy
11. rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences
12. O.32Genome editing of expanded CTG repeats within the human DMPK gene reduces nuclear RNA foci in muscle of DM1 mice
13. Downregulation of the Glial GLT1 Glutamate Transporter and Purkinje Cell Dysfunction in a Mouse Model of Myotonic Dystrophy
14. Proteomic evaluation of Pip6a-PMO treatment for myotonic dystrophy type 1
15. Incidence and predictors of venous thromboembolism in inherited myopathies: A higher risk in myotonic dystrophy
16. CRISPR/Cas9-Induced (CTGCAG)n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing
17. Survival in myotonic dystrophy type 1 predicted by the new DM1 survival risk score
18. CRISPR/Cas9-mediated genome editing corrects splicing alterations in myotonic dystrophy type 1
19. Association between mutation size and cardiac involvement in myotonic dystrophy type 1: an analysis of the DM1-heart registry
20. Development of a MBNLΔ decoy-based gene therapy for myotonic dystrophy
21. Association between mutation size and cardiac involvement in myotonic dystrophy type 1: when size matters
22. Correlation between mutation size and cardiac involvement in myotonic dystrophy type 1: An analysis of the DM1-heart registry
23. Therapeutic Approaches for Dominant Muscle Diseases: Highlight on Myotonic Dystrophy
24. MyoD transcription factor induces myogenesis by inhibiting Twist-1 through miR-206
25. P.279 - Development of a MBNLΔ decoy-based gene therapy for myotonic dystrophy
26. P.278 - CRISPR/Cas9-mediated genome editing corrects splicing alterations in myotonic dystrophy type 1
27. P.270 - Survival in myotonic dystrophy type 1 predicted by the new DM1 survival risk score
28. P.269 - Association between mutation size and cardiac involvement in myotonic dystrophy type 1: an analysis of the DM1-heart registry
29. P22 High content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC independent pathway in myotonic dystrophy cell lines
30. New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). The International Myotonic Dystrophy Consortium (IDMC)
31. New nomenclature and DNA testing guidelines for myotonic dystrophy type 1(DM1)
32. New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1)
33. P.362 - Correlation between mutation size and cardiac involvement in myotonic dystrophy type 1: An analysis of the DM1-heart registry
34. Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy.
35. P74 Observations on oligo-based therapy for Myotonic Dystrophy
36. P81 Compound screening in myotonic dystrophy
37. Gain of RNA function in pathological cases: Focus on myotonic dystrophy
38. O.6 Antisense approach for myotonic dystrophy
39. P1-19 Dérégulation de l’épissage de Tau par MBNL1 dans une Tauopathie
40. G.P.12.01 Immunodetection of myotubularin in human tissues: A diagnostic tool for X-linked myotubular myopathy
41. D.P.4.08 P16 triggers premature senescence of congenital DM1 myoblasts
42. D.P.4.09 Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles
43. D.P.4.10 Muscleblind-like proteins: Similarities and differences in normal and myotonic dystrophy muscle
44. G.P.3.01 The use of immortalised human fibroblasts from a DMD patient to test exon skipping in vivo
45. G.P.14.09 Functional characterization of skeletal muscles in DM1 mice
46. T.O.4 Ribozyme-based gene therapy reverses muscle atrophy in a mouse model of myotonic dystrophy
47. L'IGF-1 induit une augmentation de la taille et du contenu en myosine des myotubes humains
48. Extended AmplificationIn Vitroand Replicative Senescence: Key Factors Implicated in the Success of Human Myoblast Transplantation
49. Glutathione peroxidase-mediated inhibition of DNA damage and apoptosis induced by 6-hydroxydopamine in neuroblastoma cells
50. Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.